HK Stock Market Move | HELENS (09869) rose more than 17% against the market trend, with the company planning to repurchase shares in the open market. The repurchase limit will not exceed 10% of the total share capital.
Helen Electric (09869) rose more than 17% against the market, as of the time of writing, it increased by 15.46% to 1.12 Hong Kong dollars, with a turnover of 445.12 million Hong Kong dollars.
HELENS (09869) surged more than 17% against the market trend, and as of the time of this report, it had risen by 15.46% to 1.12 Hong Kong dollars, with a trading volume of 445.12 million Hong Kong dollars.
On the news front, HELENS announced that shareholders had approved a general and unconditional authorization to the directors on May 14 to repurchase up to 10% of the total issued shares at the annual general meeting (not exceeding 127 million shares). On November 6, the board of directors decided to exercise the share repurchase authorization, planning to repurchase a number of shares not exceeding the authorized amount using existing internal financial resources in the open market.
The company believes that the current trading price of the shares does not fully reflect the company's intrinsic value. The share repurchase reflects the company's long-term confidence in its business growth prospects and financial position, enhancing the net asset value and profitability per share, and is in the best interests of the company and shareholders.
Related Articles

SHINEWAY PHARM (02877) had a revenue of 2.415 billion RMB in the first three quarters, a decrease of 16.3% year-on-year.

FIRST PACIFIC (00142) has completed the proposed demerger of MAYNILAD WATER SERVICES, INC. and will independently list on the Philippine Stock Exchange.

BOAN BIOTECH (06955): Two types of Dexu Monoclonal Antibody Injections have been accepted for market approval in the United Kingdom.
SHINEWAY PHARM (02877) had a revenue of 2.415 billion RMB in the first three quarters, a decrease of 16.3% year-on-year.

FIRST PACIFIC (00142) has completed the proposed demerger of MAYNILAD WATER SERVICES, INC. and will independently list on the Philippine Stock Exchange.

BOAN BIOTECH (06955): Two types of Dexu Monoclonal Antibody Injections have been accepted for market approval in the United Kingdom.

RECOMMEND

SERES Faces Market Test in Hong Kong: Shares Open Below Issue Price Despite HK$220 Billion Market Valuation
06/11/2025

Copper Prices Surge While Former “Copper King” Who Outpaced Huawei and Tencent Falls into Decline
06/11/2025

National Energy Administration Reports New-Type Energy Storage Capacity Exceeds 100 Million Kilowatts by End‑September
06/11/2025


